# Alaunos Therapeutics, Inc.: Form 8-K, filed Oct 13, 2026

- Company: [Alaunos Therapeutics, Inc.](/companies/tcrt.md) (CIK 1107421)
- Form: 8-K
- Filed: 2026-10-13
- Accepted by EDGAR: Oct 13, 2026, 13:28 ET
- Period: 2026-10-13
- Accession: 0001193125-26-419829
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1107421/000119312526419829/tcrt-20261013.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1107421/000119312526419829/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1107421/000119312526419829/tcrt-20261013.htm

Filed Oct 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-419829. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.